Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
5 "Jeong-Eun Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Special Articles
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022
Eun Hye Park, Kyu-Won Jung, Nam Ju Park, Mee Joo Kang, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Kui Son Choi, Han-Kwang Yang, The Community of Population-Based Regional Cancer Registries
Cancer Res Treat. 2025;57(2):312-330.   Published online March 11, 2025
DOI: https://doi.org/10.4143/crt.2025.264
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2022, with international comparisons.
Materials and Methods
Cancer incidence, survival, and prevalence rates were calculated using the Korea National Cancer Incidence Database (1999-2022), with survival follow-up until December 31, 2023. Mortality data obtained from Statistics Korea, while international comparisons were based on GLOBOCAN data.
Results
In 2022, 282,047 newly diagnosed cancer cases (age-standardized rate [ASR], 287.0 per 100,000) and 83,378 deaths from cancer (ASR, 65.7 per 100,000) were reported. The proportion of localized-stage cancers increased from 45.6% in 2005 to 50.9% in 2022. Stomach, colorectal, and breast cancer showed increased localized-stage diagnoses by 18.1, 18.5, and 9.9 percentage points, respectively. Compared to 2001-2005, the 5-year relative survival (2018-2022) increased by 20.4 percentage points for stomach cancer, 7.6 for colorectal cancer, and 5.6 for breast cancer. Korea had the lowest cancer mortality among countries with similar incidence rates and the lowest mortality-to-incidence (M/I) ratios for these cancers. The 5-year relative survival (2018-2022) was 72.9%, contributing to over 2.59 million prevalent cases in 2022.
Conclusion
Since the launch of the National Cancer Screening Program in 2002, early detection has improved, increasing the diagnosis of localized-stage cancers and survival rates. Korea recorded the lowest M/I ratio among major comparison countries, demonstrating the effectiveness of its National Cancer Control Program.

Citations

Citations to this article as recorded by  
  • Regional population decline and health screening uptake in Korean adults: nationwide study using multilevel regression analysis
    Wonjeong Jeong, Woorim Kim, Kyu-Tae Han
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • The Impact of Advanced Care Planning on Hospice Utilization in Patients with Cancer: A Nationwide Analysis in Korea
    Woorim Kim, Boram Kim, Minju Kim, Jin Young Choi
    Cancers.2025; 17(9): 1471.     CrossRef
  • Personalizing perioperative therapy in muscle-invasive bladder cancer: balancing oncologic benefit, toxicity, and the risk of overtreatment
    Geehyun Song, Whi-An Kwon, Eui Hyun Jung, Dai Hong Phuc Vo, Ho Trong Tan Truong, Ho Kyung Seo
    Journal of the Korean Medical Association.2025; 68(4): 215.     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shin Je Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyo
    International Journal of Thyroidology.2025; 18(1): 30.     CrossRef
  • The volume of Gleason grade group 1 prostate cancer at biopsy predicts unfavorable pathology but not upgrading after radical prostatectomy
    Tae Ho Hwang, Young Dong Yu, Kyung Hwa Choi, Seung Ryeol Lee, Young Kwon Hong, Dong Soo Park, Tae Heon Kim
    International Urology and Nephrology.2025;[Epub]     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shinje Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyon
    Endocrinology and Metabolism.2025; 40(3): 307.     CrossRef
  • 6,750 View
  • 300 Download
  • 3 Web of Science
  • 6 Crossref
Close layer
Prediction of Cancer Incidence and Mortality in Korea, 2025
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Kui Son Choi, Han-Kwang Yang
Cancer Res Treat. 2025;57(2):331-338.   Published online March 11, 2025
DOI: https://doi.org/10.4143/crt.2025.263
AbstractAbstract PDFPubReaderePub
Purpose
This study aimed to project cancer incidence and mortality for 2025 to estimate Korea’s current cancer burden.
Materials and Methods
Cancer incidence data from 1999 to 2022 were obtained from the Korea National Cancer Incidence Database, while cancer mortality data from 1993 to 2023 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2025. A joinpoint regression model was applied to identify significant changes in trends, using only the most recent trend data for predictions.
Results
A total of 304,754 new cancer cases and 84,019 cancer deaths are expected in Korea in 2025. The most commonly diagnosed cancer is projected to be thyroid cancer, followed by the colorectal, lung, breast, prostate and stomach cancers. These six cancers are expected to account for 63.8% of the total cancer burden. Lung cancer is expected to be the leading cause of cancer-related deaths, followed by liver, colorectal, pancreatic, stomach, and gallbladder cancers, together comprising 66.6% of total cancer deaths.
Conclusion
The increasing incidence of female breast cancer and the rise in prostate and pancreatic cancers are expected to continue. As aging accelerates, cancer commonly found in older adults are projected to rise significantly.

Citations

Citations to this article as recorded by  
  • The volume of Gleason grade group 1 prostate cancer at biopsy predicts unfavorable pathology but not upgrading after radical prostatectomy
    Tae Ho Hwang, Young Dong Yu, Kyung Hwa Choi, Seung Ryeol Lee, Young Kwon Hong, Dong Soo Park, Tae Heon Kim
    International Urology and Nephrology.2025;[Epub]     CrossRef
  • 4,237 View
  • 188 Download
  • 1 Crossref
Close layer
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021
Eun Hye Park, Kyu-Won Jung, Nam Ju Park, Mee Joo Kang, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries
Cancer Res Treat. 2024;56(2):357-371.   Published online March 13, 2024
DOI: https://doi.org/10.4143/crt.2024.253
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2021.
Materials and Methods
Incidence, survival, and prevalence rates of cancer were calculated using the Korea National Cancer Incidence Database, from 1999 to 2021, with survival follow-up until December 31, 2022. Deaths from cancer were assessed using causes-of-death data obtained from Statistics Korea.
Results
The number of new cancer diagnoses in 2021 increased by 27,002 cases (10.8%) compared to 2020. In 2021, newly diagnosed cancer cases and deaths from cancer were reported as 277,523 (age-standardized rate [ASR], 289.3 per 100,000) and 82,688 (ASR, 67.6 per 100,000), respectively. The overall cancer incidence rates increased by 3.3% annually from 1999 to 2012, and decreased by 5.3% from 2012 to 2015, thereafter, followed by non-significant changes. Cancer mortality rates have been decreasing since 2002, with more rapid decline in recent years (annual decrease of 2.8% from 2002 to 2013; 3.2% from 2013 to 2021). The 5-year relative survival between 2017 and 2021 was 72.1%, which contributed to prevalent cases reaching over 2.4 million in 2021.
Conclusion
In 2021, the number of newly diagnosed cancer patients increased as healthcare utilization recovered from the coronavirus disease 2019–related declines of 2020. Revised cancer registration guidelines expanded the registration scope, particularly for stomach and colorectal cancer. Survival rates have improved over the years, leading to a growing population of cancer survivors, necessitating a comprehensive cancer control strategy. The long-term impact of the pandemic on cancer statistics requires future investigation.

Citations

Citations to this article as recorded by  
  • Determining risk‐adapted starting age and interval for breast cancer screening based on reproductive and hormonal factors
    Tung Hoang, Jeonghee Lee, So‐Youn Jung, Jeongseon Kim
    International Journal of Cancer.2025; 156(9): 1692.     CrossRef
  • Survivorship concerns among posttreatment cancer survivors in South Korea: A secondary analysis of a cross-sectional survey
    Soo Hyun Kim
    International Journal of Nursing Studies.2025; 162: 104982.     CrossRef
  • Risk of malignant lymphoma in patients with previous tuberculosis infection: a cohort study
    Yun-Gyoo Lee, Dayeon Seo, Hyun-Il Gil, Dong-Hoe Koo, Suk Joong Oh
    Annals of Hematology.2025;[Epub]     CrossRef
  • Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)
    In-Ho Kim, Seung Joo Kang, Wonyoung Choi, An Na Seo, Bang Wool Eom, Beodeul Kang, Bum Jun Kim, Byung-Hoon Min, Chung Hyun Tae, Chang In Choi, Choong-kun Lee, Ho Jung An, Hwa Kyung Byun, Hyeon-Su Im, Hyung-Don Kim, Jang Ho Cho, Kyoungjune Pak, Jae-Joon Kim
    Journal of Gastric Cancer.2025; 25(1): 5.     CrossRef
  • Sex Differences in Clinical Features and Survival Outcomes of Esophageal Cancer: A Comparative Study in the Korean Population
    Jin Hee Noh, Hyungchul Park, Do Hoon Kim, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Kee Wook Jung, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung
    The World Journal of Men's Health.2025;[Epub]     CrossRef
  • Factors Influencing Postoperative Quality of Life in Korean Brain Tumor Survivors
    Soomin Lim, Smi Choi-Kwon
    Journal of Neuroscience Nursing.2025; 57(2): 74.     CrossRef
  • A pharmacoinformatic approach for studying Atractylodes Lancea DC’s anticancer potential and control ROS-mediated apoptosis against prostate cancer cells
    Chi-Hoon Ahn, Ji Soo Myong, Kazi Rejvee Ahmed, Md Ataur Rahman, Md. Maharub Hossain Fahim, Min Choi, Muntajin Rahman, Jinwon Choi, Kiryang Kim, Seungjoon Moon, Mohammed Dalli, Rony Abdi Syahputra, Sang-Won Shin, Abdel Halim Harrath, Moon Nyeo Park, Bongle
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
    Sung-Hoon Jung, Youngil Koh, Min Kyoung Kim, Jin Seok Kim, Joon Ho Moon, Chang-Ki Min, Dok Hyun Yoon, Sung-Soo Yoon, Je-Jung Lee, Chae Moon Hong, Ka-Won Kang, Jihyun Kwon, Kyoung Ha Kim, Dae Sik Kim, Sung Yong Kim, Sung-Hyun Kim, Yu Ri Kim, Young Rok Do,
    Blood Research.2025;[Epub]     CrossRef
  • Dietary isoflavone intake among breast cancer survivors and cancer-free women
    Sihan Song, Hyeong-Gon Moon, Dong-Young Noh, So-Youn Jung, Eun Sook Lee, Zisun Kim, Hyun Jo Youn, Jihyoung Cho, Young Bum Yoo, Se Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Yoo Seok Kim, Jun Won Min, Shinyoung Jun, Hyojee Joung, Jung Eun Lee
    Nutrition Research and Practice.2025; 19(1): 80.     CrossRef
  • Return-to-Work Support Needs and Influencing Factors Among Korean Young Adult Cancer Survivors: A Cross-Sectional Study
    Kisook Kim, Hyohyeon Yoon
    Oncology Nursing Forum.2025; 52(2): 151.     CrossRef
  • Principal component analysis and fine-tuned vision transformation integrating model explainability for breast cancer prediction
    Huong Hoang Luong, Phuc Phan Hong, Dat Vo Minh, Thinh Nguyen Le Quang, Anh Dinh The, Nguyen Thai-Nghe, Hai Thanh Nguyen
    Visual Computing for Industry, Biomedicine, and Art.2025;[Epub]     CrossRef
  • Author's responses to “Comment on Kim (2025) ‘Survivorship concerns among posttreatment cancer survivors in South Korea: A secondary analysis of a cross-sectional survey’”
    Soo Hyun Kim
    International Journal of Nursing Studies.2025; 166: 105039.     CrossRef
  • Post-gastrectomy anemia and ferritin dynamics: key determinants of prognosis and clinical management in patients with gastric cancer
    Eun Young Kim, Kyo Young Song, Dong Jin Kim
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • It is never too late to stop smoking. Applying working estimates of smoking cessation on five-year overall survival gains after a cancer diagnosis
    Nouhad El-Haddad, Yang Li, Geoff P. Delaney, Heewon Kang, Shalini Vinod, Margo Barr, Takahiro Tabuchi, Michael Kidd, Freddy Sitas
    Cancer Epidemiology.2025; 96: 102775.     CrossRef
  • A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients
    Hyunho Han, Ik Jae Lee, Woong Sub Koom, Chan Woo Wee, Woong Kyu Han
    Journal of Urologic Oncology.2025; 23(1): 20.     CrossRef
  • Laparoscopic and robotic surgery for colorectal cancer in Korea: a nationwide health insurance database analysis from 2019 to 2023
    Eun Ji Park, Hyun Gu Lee, Youn Young Park, Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
    Journal of Minimally Invasive Surgery.2025; 28(1): 25.     CrossRef
  • Current status of endoscopy training for surgeons in Korea: a narrative review
    Dae Kyung Sohn
    Journal of Minimally Invasive Surgery.2025; 28(1): 1.     CrossRef
  • Cancer risk according to lifestyle risk score trajectories: a population-based cohort study
    Thi Minh Thu Khong, Thi Tra Bui, Hee-Yeon Kang, Eunjung Park, Moran Ki, Yoon-Jung Choi, Byungmi Kim, Jin-Kyoung Oh
    BJC Reports.2025;[Epub]     CrossRef
  • Mortality Risk According to Changes in Alcohol Consumption Post‐Diagnosis Among Liver Cancer Patients
    Thi Tra Bui, Eunjung Park, Hee‐Yeon Kang, Byungmi Kim, Young‐Joo Won, Jin‐Kyoung Oh
    Liver International.2025;[Epub]     CrossRef
  • Plasma metabolite based clustering of breast cancer survivors and identification of dietary and health related characteristics: an application of unsupervised machine learning
    Ga-Eun Yie, Woojin Kyeong, Sihan Song, Zisun Kim, Hyun Jo Youn, Jihyoung Cho, Jun Won Min, Yoo Seok Kim, Jung Eun Lee
    Nutrition Research and Practice.2025; 19(2): 273.     CrossRef
  • Time-trend costs of infection-related cancers in Japan: a systematic review
    Trinh Xuan Thi Nguyen, Sumeet Lal, Sulemana Abdul-Salam
    Discover Public Health.2025;[Epub]     CrossRef
  • Conditional Relative Survival of Gallbladder Cancer: A Population-Based Study in a High-Incidence Asian Country from 1999 to 2021
    Mee Joo Kang, Johyun Ha, Sang-Jae Park, Hyeong Min Park, Kyu-Won Jung, Sung-Sik Han
    Annals of Surgical Oncology.2025;[Epub]     CrossRef
  • Iron Consumption and Colorectal Cancer in Korean Adults: A Prospective Cohort Study
    Sukhong Min, Katherine De la Torre, Hyobin Lee, Woo-Kyoung Shin, Daehee Kang
    Nutrients.2025; 17(8): 1309.     CrossRef
  • Diagnosis and Treatment of HER2-Positive Breast Cancer
    Suee Lee
    The Korean Journal of Medicine.2025; 100(2): 81.     CrossRef
  • Evaluation of internal scatter contribution to gonadal dose in colorectal radiotherapy
    Hyojun Park, Jung-In Kim, Chang Heon Choi, Jong Min Park, Seonghee Kang, Hyeongmin Jin, Eui Kyu Chie, Jaeman Son
    Biomedical Physics & Engineering Express.2025; 11(3): 035009.     CrossRef
  • Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry
    Jihyun An, Young Chang, Gwang Hyeon Choi, Won Sohn, Jeong Eun Song, Hyunjae Shin, Jae Hyun Yoon, Jun Sik Yoon, Hye Young Jang, Eun Ju Cho, Ji Won Han, Suk Kyun Hong, Ju-Yeon Cho, Kyu-Won Jung, Eun Hye Park, Eunyang Kim, Bo Hyun Kim
    Journal of Liver Cancer.2025; 25(1): 109.     CrossRef
  • Use of Pulmonary Rehabilitation for Lung Cancer Patients in Korea: Analysis of the National Health Insurance Service Database
    Sang Hun Kim, Cho Hui Hong, Jong-Hwa Jeong, Jinmi Kim, Jeong Su Cho, Jin A Yoon, Jung Seop Eom, Byeong Ju Lee, Myung Hun Jang, Myung-Jun Shin, Yong Beom Shin
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Prediction of Cancer Incidence and Mortality in Korea, 2025
    Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Kui Son Choi, Han-Kwang Yang
    Cancer Research and Treatment.2025; 57(2): 331.     CrossRef
  • Changes in Cancer Care for Patients Aged 80 and Above: A Cohort Study from Samsung Comprehensive Cancer Center in South Korea
    Seung Tae Kim, Danbee Kang, Seok Jin Kim, Jun Ho Lee, Hong Kwan Kim, Yong Beom Cho, Yong Han Paik, Seok Won Kim, Byong Chang Jeong, Ho Jun Seol, Man Ki Chung, Kyu Taek Lee, Kihyun Kim, Sung-wook Seo, Jeong-Won Lee, Hee Chul Park, Dong Wook Shin, Juhee Cho
    Cancers.2025; 17(12): 2017.     CrossRef
  • Trends, patterns, and risk factors of esophageal cancer mortality in China, 2008–2021: A National Mortality Surveillance System data analysis
    Yunfei Jiao, Tinglu Wang, Lin Fu, Ye Gao, Zhiyuan Cheng, Lei Xin, Jinfang Xu, Han Lin, Wei Wang, Maigeng Zhou, Jinlei Qi, Zhaoshen Li, Luowei Wang
    Journal of Advanced Research.2025;[Epub]     CrossRef
  • Feasibility and preliminary efficacy of an artificial intelligence-based cancer survivorship care plan service using digital platforms: a single-arm prospective pilot study
    Soo Hyun Kim, Shin-Young Park, Sung Mook Lim, Hyemin Yi
    Journal of Cancer Survivorship.2025;[Epub]     CrossRef
  • Desorption and reusability of adsorbent Diaion HP-20 for the recovery of paclitaxel from culture supernatants of Taxus chinensis
    Yeji Kang, Jin-Hyun Kim
    Biotechnology and Bioprocess Engineering.2025; 30(3): 573.     CrossRef
  • The Development of Diagnostic Nuclear Medicine Imaging in Korea and Recent Trends in Radiopharmaceuticals for Pancreaticobiliary Diseases
    Byungwook Choi
    The Korean Journal of Pancreas and Biliary Tract.2025; 30(2): 62.     CrossRef
  • Personalizing perioperative therapy in muscle-invasive bladder cancer: balancing oncologic benefit, toxicity, and the risk of overtreatment
    Geehyun Song, Whi-An Kwon, Eui Hyun Jung, Dai Hong Phuc Vo, Ho Trong Tan Truong, Ho Kyung Seo
    Journal of the Korean Medical Association.2025; 68(4): 215.     CrossRef
  • Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery
    Jeon Yeob Jang, Geun-Jeon Kim, Sang-Yeon Kim, Min-Su Kim, Dong Kun Lee, Minsu Kwon, Dongbin Ahn, Myung Jin Ban, Young Kang, Ho-Ryun Won, Jae Won Chang, Dong Won Lee, Ki Nam Park, Yeon Soo Kim, Ah Ra Jung, Jungirl Seok, Hye Ran Lee, Sung-Chan Shin, Chang M
    Clinical and Experimental Otorhinolaryngology.2025; 18(2): 89.     CrossRef
  • Changes in Physical Activity and Mortality Risk among Korean Cancer Survivors: A Population-Based Cohort Study
    Thi Tra Bui, Eunjung Park, Hee-Yeon Kang, Byungmi Kim, Jin-Kyoung Oh
    Cancer Epidemiology, Biomarkers & Prevention.2025; 34(6): 1016.     CrossRef
  • FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma
    Elizabeth C. Smyth, Kyoung-Mee Kim, Sun Young Rha, Zev A. Wainberg, Hayden Honeycutt, Erica Sommermann, Atsushi Ochiai
    Cancer Treatment Reviews.2025; : 102971.     CrossRef
  • Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR‐Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study
    Mi‐Hyun Kim, Min Ki Lee, Ji Eun Park, Sun Hyo Park, Tae Won Jang, Chi Young Jung, Insu Kim, Seong Hoon Yoon, June Hong Ahn, Hyun‐Kyung Lee, Jin Han Park, Sun Ha Choi, Jung Seop Eom
    Thoracic Cancer.2025;[Epub]     CrossRef
  • Cost-effectiveness of adding Helicobacter pylori screening to the National Gastric Cancer Screening Program in Korea (Preprint)
    Seowoo Bae, Joon Sung Kim, Moon Won Lee Lee, Gwang Ha Kim, Young-Il Kim, Woon Tae Jung, Gwang Ho Baik Baik, Beom Jin Kim, Joongyub Lee, Mina Suh, Jae Gyu Kim
    JMIR Research Protocols.2025;[Epub]     CrossRef
  • Colorectal Cancer Survivors' Inner Strength, Multiple Identities, and Quality of Life by Gender and Ostomy Presence: A Cross-Sectional Study
    Hannah Yu, Eunjung Ryu
    Korean Journal of Adult Nursing.2024; 36(2): 171.     CrossRef
  • Chuna Manual Therapy or Electroacupuncture with Pregabalin for Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Pilot Study
    Yeon-Woo Lee, Ilkyun Lee, Jin-Hyun Lee, Min-Geun Park, Ji-Hoon Kim, Yoon-Young Sunwoo, Man-Suk Hwang, Tae-Yong Park
    Journal of Clinical Medicine.2024; 13(13): 3916.     CrossRef
  • SMARCD3 Overexpression Promotes Epithelial–Mesenchymal Transition in Gastric Cancer
    Sun Yi Park, Ji-Ho Park, Jung Wook Yang, Eun-Jung Jung, Young-Tae Ju, Chi-Young Jeong, Ju-Yeon Kim, Taejin Park, Tae-Han Kim, Miyeong Park, Young-Joon Lee, Sang-Ho Jeong
    Cancers.2024; 16(12): 2282.     CrossRef
  • Factors influencing psychological distress among breast cancer survivors using machine learning techniques
    Jin-Hee Park, Misun Chun, Sun Hyoung Bae, Jeonghee Woo, Eunae Chon, Hee Jun Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • The Influence of Professional Self-Concept and Patient Safety Culture on Burnout among Nurses in a Cancer Hospital
    Soyoon Do, Eunjung Ryu
    Asian Oncology Nursing.2024; 24(2): 53.     CrossRef
  • Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas
    Tae-Woo Kim, Kiyong Na, Junyang Jung, Heejin Lim, Hyewon Seo, Seung Hyeun Lee
    Oncology.2024; 102(11): 969.     CrossRef
  • Performance of the National Cancer Screening Program for Gastric Cancer in Korea
    Young-Il Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2024; 24(3): 231.     CrossRef
  • Sites of Metastasis and Survival in Metastatic Renal Cell Carcinoma: Results From the Korean Renal Cancer Study Group Database
    Chan Ho Lee, Minyong Kang, Cheol Kwak, Young Hwii Ko, Jung Kwon Kim, Jae Young Park, Seokhwan Bang, Seong Il Seo, Jungyo Suh, Wan Song, Cheryn Song, Hyung Ho Lee, Jinsoo Chung, Chang Wook Jeong, Jung Ki Jo, Seock Hwan Choi, Joongwon Choi, Changil Choi, Se
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study
    Ji Won Han, Won Sohn, Gwang Hyeon Choi, Jeong Won Jang, Gi Hyeon Seo, Bo Hyun Kim, Jong Young Choi
    Journal of Liver Cancer.2024; 24(2): 274.     CrossRef
  • Redefining the role of radiation therapy in pancreatic cancer management: innovations and future directions: A narrative review
    Jeong Il Yu
    Precision and Future Medicine.2024; 8(3): 74.     CrossRef
  • A 5-Year Mortality Prediction Model for Prostate Cancer Patients Based on the Korean Nationwide Health Insurance Claims Database
    Joungyoun Kim, Yong-Hoon Kim, Yong-June Kim, Hee-Taik Kang
    Journal of Personalized Medicine.2024; 14(10): 1058.     CrossRef
  • Longitudinal trajectories of frailty and cognitive decline among older Korean cancer survivors
    Ran Won, Heesook Son, Jeehee Han, Youn-Jung Son
    Geriatric Nursing.2024; 60: 636.     CrossRef
  • Breast Cancer Statistics in Korea, 2021
    Chihwan David Cha, Chan Sub Park, Hee-Chul Shin, Jaihong Han, Jung Eun Choi, Joo Heung Kim, Kyu-Won Jung, Sae Byul Lee, Sang Eun Nam, Tae In Yoon, Young-Joon Kang, Zisun Kim, So-Youn Jung, Hyun-Ah Kim
    Journal of Breast Cancer.2024; 27(6): 351.     CrossRef
  • Tobacco Use in Korea: Current Epidemiology and Public Health Issues
    Jong Eun Park, Woo Min Jeong, Ye Jin Choi, So Young Kim, Kyoung Eun Yeob, Jong Hyock Park
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Endometrial cancer detected unusually after an ankle fracture secondary to severe anemia in an obese woman with heavy menstrual bleeding: A case report
    Hyung Yoon, Tae Go, Kyung Kim, Yong Song, Dong Suh, Ki Kim
    Molecular and Clinical Oncology.2024;[Epub]     CrossRef
  • Updates in the 2024 Korean Thyroid Association Clinical Practice Guidelines for Differentiated Thyroid Cancer: from Diagnosis to Initial Treatment
    Eun Kyung Lee
    International Journal of Thyroidology.2024; 17(2): 259.     CrossRef
  • A Case Study of Korean Medicine in Treating Worsened Esophagitis Symptoms Following Anticancer Therapy in a Patient with Esophageal Cancer
    Eun-seo Kim, Soo-min Jo, Si-young Song, Geun-jeong Kim, Young-su Lee
    The Journal of Internal Korean Medicine.2024; 45(5): 895.     CrossRef
  • The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
    Jong Ho Park, Jong Jin Oh
    Journal of Urologic Oncology.2024; 22(3): 246.     CrossRef
  • Adherence to the Cancer Prevention Recommendations from World Cancer Research Fund/American Institute for Cancer Research After Cancer Diagnosis on Mortality in South Korea
    Donghyun Won, Jeeyoo Lee, Sooyoung Cho, Ji Yoon Baek, Daehee Kang, Aesun Shin
    Nutrients.2024; 16(23): 4049.     CrossRef
  • Trends in Thyroid Cancer Mortality Rates in Korea: Insights from National Health Database
    Won Gu Kim
    Endocrinology and Metabolism.2024; 39(6): 853.     CrossRef
  • Impact of Early Oral Feeding on Postoperative Outcomes after Elective Colorectal Surgery: A Systematic Review and Meta-Analysis
    Soo Young Lee, Eon Chul Han
    Digestive Surgery.2024; : 1.     CrossRef
  • Nationwide Incidence Trends of Pediatric Parotid Malignancy in Korea and a Retrospective Analysis of Single-Institution Surgical Experience of Parotidectomy
    Hyun Seong Kim, Seo Young Kim, Eun-Jae Chung, Seong Keun Kwon, Soon-Hyun Ahn, Yuh-Seog Jung, Jungirl Seok
    Korean Society of Head and Neck Oncology.2024; 40(2): 7.     CrossRef
  • Total gastrectomy patients had a lower diet volume and greater diet frequency than distal gastrectomy patients after 6 months
    Ye-Ji Kim, Sang-Ho Jeong, Eun-Jung Jung, Taejin Park, Jin-Kwon Lee, Tae-Han Kim, Young-Hye Kim, Jae-Seok Min, Miyeong Park, Young-Joon Lee
    Medicine.2024; 103(51): e40878.     CrossRef
  • Quality of life outcomes in terminal cancer patients attending regional cancer centers in South Korea: protocol for a prospective cohort study
    Jung hye Kwon, Jung Hun Kang, Jung-Sik Huh, Su-Jin Koh, Kyu-Hyoung Lim, Byungho Choi, Rock Bum Kim, Young Jin Choi, Eun-Kee Song, Hyun Woo Lee, Ye-Seul Kim, Se-Il Go, Hwan Jung Yun, Sun Jin Sym, Hyewon Ryu, Myung-won Lee
    BMC Cancer.2024;[Epub]     CrossRef
  • Beyond survival: a comprehensive review of quality of life in rectal cancer patients
    Won Beom Jung
    Annals of Coloproctology.2024; 40(6): 527.     CrossRef
  • Post-colonoscopy Colorectal Cancer: Causes and Prevention
    Jong Yoon Lee
    Journal of Digestive Cancer Research.2024; 12(3): 160.     CrossRef
  • 12,603 View
  • 581 Download
  • 54 Web of Science
  • 65 Crossref
Close layer
Prediction of Cancer Incidence and Mortality in Korea, 2024
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
Cancer Res Treat. 2024;56(2):372-379.   Published online March 11, 2024
DOI: https://doi.org/10.4143/crt.2024.252
AbstractAbstract PDFPubReaderePub
Purpose
This study aimed to report the projected cancer incidence and mortality for the year 2024 to estimate Korea’s current cancer burden.
Materials and Methods
Cancer incidence data from 1999 to 2021 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2022 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and multiplying the projected age-specific rates by the anticipated age-specific population for 2024. A joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend for prediction.
Results
In total, 292,221 new cancer cases and 83,770 cancer deaths are expected to occur in Korea in 2024. The most common cancer site is expected to be the thyroid, followed by the colon and rectum, lung, breast, and stomach. These five cancers are expected to represent 55.7% of the overall burden of cancer in Korea. The most common type of cancer leading to death is expected to be lung cancer, followed by liver, colorectal, pancreatic, and stomach cancers.
Conclusion
The age-standardized incidence rates for female breast and prostate cancers are estimated to continue to increase. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.

Citations

Citations to this article as recorded by  
  • Efficacy and safety of herbal medicine treatment on postsurgical recovery in gastric cancer patients: A systematic review and meta-analysis
    Soo-Dam Kim, Sook-Jin Pyo, Dong-Hyeon Kim, Hwa-Seung Yoo, So-Jung Park
    Medicine.2025; 104(1): e41034.     CrossRef
  • Comparison of definitive radiotherapy outcomes between younger and older patients with high- or very-high-risk prostate cancer
    Yong-Hyub Kim, Jae-Uk Jeong, Jung-Ho Yang, Taek-Keun Nam, Ju-Young Song, Mee Sun Yoon, Shinhaeng Cho, Sung-Ja Ahn
    Radiotherapy and Oncology.2025; 205: 110763.     CrossRef
  • Association Between Prostate Cancer Detection Rate and Year of Prostate Biopsy
    Young Jun Uhm, Woojin Bang, Jae Hoon Chung, Cheol Young Oh, Hwanik Kim, Jin Seon Cho
    Life.2025; 15(2): 260.     CrossRef
  • Association between sedentary behavior, depressive symptoms, and the risk of all-cause and cause-specific mortality among U.S. cancer survivors
    Ping Yao, Ying Zhong, Zhigong Wei
    BMC Cancer.2025;[Epub]     CrossRef
  • A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients
    Hyunho Han, Ik Jae Lee, Woong Sub Koom, Chan Woo Wee, Woong Kyu Han
    Journal of Urologic Oncology.2025; 23(1): 20.     CrossRef
  • Regional population decline and health screening uptake in Korean adults: nationwide study using multilevel regression analysis
    Wonjeong Jeong, Woorim Kim, Kyu-Tae Han
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • Improved Prognostic Stratification With 2023 International Federation of Gynecology and Obstetrics Staging in Endometrial Cancer Reflecting Poor Prognosis of Aggressive Histological Types and p53 Abnormality
    Miseon Lee, Heesoo Yoon, Ujae Kim, Jun Kang, Yeon Bi Han, Keun Ho Lee, Sung Jong Lee, Sook Hee Hong, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim, Hyojin Kim, Ahwon Lee
    Laboratory Investigation.2025; 105(9): 104189.     CrossRef
  • Prognostic Significance of RBM3 Expression in Epithelial Ovarian Cancer: A Tissue Microarray-Based Study
    Hyeong Chan Shin, Hye Won Lee, So-Jin Shin, Sun Young Kwon
    Diagnostics.2025; 15(11): 1426.     CrossRef
  • 2023 Update of the Korean Thyroid Association Guidelines for the Management of Thyroid Nodules
    Eun Kyung Lee, Young Joo Park
    Clinical Thyroidology®.2024; 36(4): 153.     CrossRef
  • The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer
    Seo Hee Choi, Seung-Hoon Beom, Young Deuk Choi, Won Sik Ham, Hyunho Han, Woong Kyu Han, Won Sik Jang, Seung Hwan Lee, Jaeho Cho
    Cancers.2024; 16(18): 3159.     CrossRef
  • Trend Analysis of Lung Cancer Incidence and Mortality in Xiamen (2011-2020)
    Jianni Cong, Jiahuang Chi, Junli Zeng, Yilan Lin
    Risk Management and Healthcare Policy.2024; Volume 17: 2375.     CrossRef
  • The Impact of the Dietary Inflammatory Index, Fasting Blood Glucose, and Smoking Status on the Incidence and Survival of Pancreatic Cancer: A Retrospective Case–Control Study and a Prospective Study
    Ga Hyun Lee, Yeon Hee Kim, Sang Myung Woo, Woo Jin Lee, Sung-Sik Han, Sang-Jae Park, Sherry Price, Penias Tembo, James R. Hébert, Mi Kyung Kim
    Nutrients.2024; 16(22): 3941.     CrossRef
  • 7,093 View
  • 317 Download
  • 11 Web of Science
  • 12 Crossref
Close layer
Original Article
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
Kyu-pyo Kim, Jeong-Eun Kim, Yong Sang Hong, Sung-Min Ahn, Sung Min Chun, Seung-Mo Hong, Se Jin Jang, Chang Sik Yu, Jin Cheon Kim, Tae Won Kim
Cancer Res Treat. 2017;49(1):161-167.   Published online July 4, 2016
DOI: https://doi.org/10.4143/crt.2015.490
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Although the mutation status of KRAS is highly concordant in primary and metastatic lesions, it has not been generalized to other major pathway genes.
Materials and Methods
In this study, 41 genes were evaluated and the mutational profiles were compared in 46 colorectal cancer patients with paired surgical specimens of primary and metastatic lesions: synchronous (n=27) and metachronous (n=19) lesions. A high-throughput mass spectrometry-based genotyping platform validated by orthogonal chemistry, OncoMap v.4.4, was used to evaluate the formalin-fixed, paraffin-embedded surgical specimens. The patients’ demographics, tumor characteristics, and microsatellite instability status were analyzed by a retrospective chart review.
Results
In this study,with OncoMap, mutationswere identified in 80.4% of patientswith the following frequency: KRAS (39.1%), TP53 (28.3%), APC (28.3%), PIK3CA (6.5%), BRAF (6.5%), and NRAS (4.3%). Although 19.6% (9/46) of the patients showed no gene mutations, 43.5% (20/46) and 37.0% (17/46) had mutations in one and two or more genes, respectively. The synchronous and metachronous lesions showed similar mutational profiles. Paired samples between primary and metastatic tumors differed in 7.4% (2/27) and 10.5% (2/19) for synchronous and metachronous according to OncoMap.
Conclusion
These findings indicate the major pathway genes, including KRAS, TP53, APC, PIK3CA, BRAF, and NRAS, are often concordant between the primary and metastatic lesions regardless of the temporal relationship of metastasis.

Citations

Citations to this article as recorded by  
  • Analysis of Shared Variants between Cancer Biospecimens
    Michael B. Foote, James Robert White, Walid K. Chatila, Guillem Argilés, Steve Lu, Benoit Rousseau, Oliver Artz, Paul Johannet, Henry Walch, Mitesh Patel, Michelle F. Lamendola-Essel, David Casadevall, Somer Abdelfattah, Shrey Patel, Rona Yaeger, Andrea C
    Clinical Cancer Research.2025; 31(2): 376.     CrossRef
  • Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment
    Pengfei Yu, Can Hu, Guangyu Ding, Xiaoliang Shi, Jingli Xu, Yang Cao, Xiangliu Chen, Wei Wu, Qi Xu, Jingquan Fang, Xingmao Huang, Shaohua Yuan, Hui Chen, Zhizheng Wang, Ling Huang, Fei Pang, Yian Du, Xiangdong Cheng
    Nature Communications.2024;[Epub]     CrossRef
  • The varied clonal trajectory of liver and lung metastases of colorectal cancer
    Ofer N. Gofrit, Ben Gofrit, S. Nahum Goldberg, Aron Popovtzer, Jacob Sosna, Ayala Hubert
    Advances in Cancer Biology - Metastasis.2024; 11: 100122.     CrossRef
  • Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers
    Jaspreet Kaur, Darshan S. Chandrashekar, Zsuzsanna Varga, Bettina Sobottka, Emiel Janssen, Khanjan Gandhi, Jeanne Kowalski, Umay Kiraz, Sooryanarayana Varambally, Ritu Aneja
    Genes.2023; 14(9): 1690.     CrossRef
  • The different clonal origins of metachronous and synchronous metastases
    Ofer N. Gofrit, Ben Gofrit, Yuval Roditi, Aron Popovtzer, Steve Frank, Jacob Sosna, Marina Orevi, S. Nahum Goldberg
    Journal of Cancer Research and Clinical Oncology.2023; 149(13): 11085.     CrossRef
  • Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish
    Ruba Hamed, Sam Marks, Helen Mcelligott, Roshni Kalachand, Hawa Ibrahim, Said Atyani, Greg Korpanty, Nemer Osman
    Molecular and Clinical Oncology.2021;[Epub]     CrossRef
  • Association of DNA repair gene polymorphisms with colorectal cancer risk and treatment outcomes
    Fawaz N. Al-Shaheri, Kamal M. Al-Shami, Eshrak H. Gamal, Amjad A. Mahasneh, Nehad M. Ayoub
    Experimental and Molecular Pathology.2020; 113: 104364.     CrossRef
  • High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
    Tuva Høst Brunsell, Anita Sveen, Bjørn Atle Bjørnbeth, Bård I. Røsok, Stine Aske Danielsen, Kristoffer Watten Brudvik, Kaja C.G. Berg, Bjarne Johannessen, Vanja Cengija, Andreas Abildgaard, Marianne Grønlie Guren, Arild Nesbakken, Ragnhild A. Lothe
    Clinical Colorectal Cancer.2020; 19(1): e26.     CrossRef
  • Case report: recurrent pituitary adenoma has increased load of somatic variants
    Raitis Peculis, Inga Balcere, Ilze Radovica-Spalvina, Ilze Konrade, Olivija Caune, Kaspars Megnis, Vita Rovite, Janis Stukens, Jurijs Nazarovs, Austra Breiksa, Aigars Kiecis, Ivars Silamikelis, Valdis Pirags, Janis Klovins
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Transcriptomic analysis by RNA sequencing characterises malignant progression of canine insulinoma from normal tissue to metastatic disease
    Y. Capodanno, F. O. Buishand, L. Y. Pang, J. Kirpensteijn, J. A. Mol, R. Elders, D. J. Argyle
    Scientific Reports.2020;[Epub]     CrossRef
  • Genetic Alterations of Metastatic Colorectal Cancer
    Ugo Testa, Germana Castelli, Elvira Pelosi
    Biomedicines.2020; 8(10): 414.     CrossRef
  • Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
    Yanglong Chen, Ying Lu, Yuting Ke, Yanling Li
    Medicine.2019; 98(39): e17221.     CrossRef
  • Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer
    Camille Evrard, Gaëlle Tachon, Violaine Randrian, Lucie Karayan-Tapon, David Tougeron
    Cancers.2019; 11(10): 1567.     CrossRef
  • Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting
    William Hankey, Wendy L. Frankel, Joanna Groden
    Cancer and Metastasis Reviews.2018; 37(1): 159.     CrossRef
  • Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells
    Ugo Testa, Elvira Pelosi, Germana Castelli
    Medical Sciences.2018; 6(2): 31.     CrossRef
  • Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients
    Fangfang Xie, Yujun Zhang, Xiaowei Mao, Xiaoxuan Zheng, Han Han-Zhang, Junyi Ye, Ruiying Zhao, Xueyan Zhang, Jiayuan Sun
    Lung Cancer.2018; 121: 54.     CrossRef
  • Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
    Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, Yuhree Kim, Doris Wagner, Kazunari Sasaki, Andrea Beer, Christoph Schwarz, Inger Marie Løes, Maria Smolle, Carsten Kamphues, Jin He, Timothy M. Pawlik, Klaus Kaczirek, George Poultsides, Per
    JAMA Surgery.2018; 153(7): e180996.     CrossRef
  • Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
    Chiara Molinari, Giorgia Marisi, Alessandro Passardi, Laura Matteucci, Giulia De Maio, Paola Ulivi
    International Journal of Molecular Sciences.2018; 19(12): 3733.     CrossRef
  • 10,920 View
  • 279 Download
  • 21 Web of Science
  • 18 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP